Ainos (NASDAQ:AIMD) Posts Earnings Results

by · The Cerbat Gem

Ainos (NASDAQ:AIMD – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.21) EPS for the quarter, Zacks reports.

Ainos Price Performance

Ainos stock traded up $0.00 during trading on Monday, reaching $0.54. The company had a trading volume of 76,803 shares, compared to its average volume of 511,867. The firm’s 50-day simple moving average is $0.52 and its 200 day simple moving average is $0.54. Ainos has a 1-year low of $0.40 and a 1-year high of $1.46. The firm has a market capitalization of $8.34 million, a PE ratio of -0.33 and a beta of 2.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.33 and a current ratio of 1.37.

Ainos Company Profile

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

Featured Stories